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1
▪ Benzodiazepines are prescribed for anxiety and insomnia. [1]
▪ Patients commonly use benzodiazepines for up to 10 years even though these medications are not meant to be used 
for more than 2 to 4 weeks. [1]
▪ Doctors are quick to prescribe benzodiazepines because they work very well for anxiety and insomnia and patients 
respond immediately to them. However, patients soon develop tolerance and experience painful withdrawal 
symptoms. [2]
▪ Patients have been harmed by benzodiazepines even though they are using them as prescribed by their doctors. [2]
▪ 23% of benzodiazepine users become addicted within 3 months. [3]
▪ Benzodiazepines eventually stop working and actually exacerbate anxiety and insomnia. [4]
▪ The benzodiazepine epidemic could become as large of a public health crisis as the current opioid epidemic. [5]
▪ 1999-2015: benzodiazepine overdose increased sevenfold. [4]
▪ 1996-2003: the number of benzodiazepine prescriptions increased 67% from 8.1 million to 13.5 million. [6]
▪ 2004-2011: the number of patients treated in the ED for benzodiazepine misuse increased 124%. [7]
2A
▪ In 2016, Xanax was the most prescribed drug in the state. 
▪ There is an increasing number of teens experimenting with the benzodiazepine, alprazolam (Xanax).
▪ Several middle and high school students have been treated in the ED following misuse of Xanax.
▪ Xanax is the second leading cause of DUI, surpassing marijuana. Alcohol is the first leading cause.
▪ In 2016, the Connecticut Department of Consumer Protection reported that:
▪ 16,000-24,000 Xanax pills were prescribed to patients in Newtown.
▪ There were 130,000 more benzodiazepine prescriptions than opioid prescriptions across the state.
[5]
2B
Based on interviews, patients in 
western Connecticut typically spend 
between $100-$300 per year buying 
benzodiazepines.
“The problem is that 
benzodiazepines are cheap. Some 
people can buy a month’s supply for 
$10. They’re not costly so they’re 
easy to get.”
-Cornelius Ferreira, MD
• Patients with generalized anxiety disorder are subject to increased healthcare 
costs from accidents and other consequences of long-term benzodiazepine 
use. [8]
• In a study of 866 patients, average healthcare costs increased by $2334 per 
patient in a 6 month period following initiation of benzodiazepine treatment. 
• $1099 of this total covered the cost of accidents and other complications 
related to benzodiazepines use. [8]
• Another study of 17,588 patients showed that over $3 million were spent on 
297 inpatient injury admissions and 2,977 outpatient injury encounters due 
to benzodiazepine use. [9]
• Benzodiazepines, themselves are not expensive but complications from their 
use generate high healthcare costs.
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Keri Reilly, LCSW
Behavioral Health Consultant, Western Connecticut Medical Group
“Patients use benzodiazepines to escape, just as some people do with heroin, cocaine, or marijuana. 
They don’t realize that misusing benzodiazepines is a form of substance abuse because they’re 
prescribed by doctors. Alternative therapies are very effective; based on screening done throughout 
multiple centers in western Connecticut, there is a 50% reduction in depression and anxiety scores 
following use of alternative therapies.”
Cornelius Ferreira, MD
Family Medicine, Western Connecticut Medical Group
I don’t think patients should use benzodiazepines as long-term therapy because of the multitude of 
side effects and other issues such as addiction, tolerance, dependence, and rebound anxiety.  These 
issues add to the problems patients already have. They would benefit more from cognitive behavioral 
therapy and relaxation techniques. There is also a multitude of other medications, such as SSRIs and 
hydroxyzine, that are effective for anxiety and insomnia.”
Katherine Michael, MD
Psychiatry, Western Connecticut Medical Group
“Benzodiazepines are good medications for a couple of nights but then they won’t work anymore. 
They’re not meant to be long-term solutions.” 4
▪ Patients have a false sense of security regarding use of benzodiazepines because they are so widely 
prescribed by physicians throughout the country. [5]
▪ To discourage use of benzodiazepines and inform patients about the dangers associated with 
benzodiazepines and the availability of safer therapies, a handout was created.
▪ The handout was distributed to patients interested in benzodiazepine treatment for anxiety or 
insomnia.
▪ A 2 question pre-handout survey and 3 question post-handout survey was given to these patients to 
assess effectiveness of the handout.
5A
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The handout is now being distributed to patients at 
Brookfield Family Medicine.
Patient 2
Recently prescribed diazepam (Valium)
Patient 1





▪ Patient 1 (10 year benzodiazepine use) did not change response after reading the handout. This patient 
has been using benzodiazepines long-term and has become dependent on them. Getting this patient to 
stop benzodiazepine use will require intervention more aggressive than a simple handout. Nevertheless, 
patient 1 found the handout helpful and would definitely (10/10 rating) recommend the handout to 
someone who is considering benzodiazepines for anxiety or insomnia. 
▪ Patient 2 (recently prescribed benzodiazepine use) became less inclined to consider benzodiazepines 
and more interested in trying alternative therapies after reading the handout. Patient 2 would also 
recommend (8/10 rating) the handout to someone who is considering benzodiazepines for anxiety or 
insomnia. 
▪ These results suggest that this handout may be effective for patients who have never tried 
benzodiazepines or patients who just recently started using them. Thus, it is important to educate 
patients about the dangers of using benzodiazepines before they initiate therapy. It is much easier to 
dissuade someone who has never tried benzodiazepines than someone who has been using them for a 
long time.
7A
▪ Sample size of 2 is very small.
▪ Limited time to distribute the handout and administer surveys to more patients.
▪ Handout was not adequate for dissuading patients who have already become dependent on 
benzodiazepines.
7B
▪ Future projects could involve interviewing patients who have opted for alternative therapies (safer 
medications, CBT, smartphone apps) and determining their satisfaction with these other options.
▪ Another useful project would involve creating a guide that explains the pros and cons of various 
smartphone apps for anxiety and insomnia. This would be helpful because there is a plethora of mental 
wellness apps and patients struggle to figure out which apps are most suitable for them. 
▪ Targeting a different population, especially middle and high school students, would also be interesting. 
This would be impactful because the growing benzodiazepine epidemic is prevalent amongst this age 
group. Future projects could involve giving a presentation to a classroom of students at a middle school 
or high school.
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